These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1078448)

  • 1. [Selection through patient dropouts in therapeutic series].
    Uberla K
    Methods Inf Med Suppl; 1976; 9():37-45. PubMed ID: 1078448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Difficulties in planning in therapeutic comparisons].
    Van de Loo J
    Methods Inf Med Suppl; 1976; 9():47-51. PubMed ID: 1078453
    [No Abstract]   [Full Text] [Related]  

  • 3. Dropouts and missing data in psychiatric clinical trials.
    Potkin SG; Siu CO
    Am J Psychiatry; 2009 Nov; 166(11):1295; author reply 1295-6. PubMed ID: 19884237
    [No Abstract]   [Full Text] [Related]  

  • 4. Issues in the analysis of clinical trials for opiate dependence.
    Follmann D; Wu M; Geller N
    NIDA Res Monogr; 1992; 128():97-113; discussion 114-5. PubMed ID: 1436019
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
    Jain RB
    NIDA Res Monogr; 1992; 128():116-34; discussion 135-6. PubMed ID: 1436010
    [No Abstract]   [Full Text] [Related]  

  • 6. Are alcoholism treatments effective? The Project MATCH data: response.
    Miller WR
    BMC Public Health; 2005 Jul; 5():76. PubMed ID: 16026611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Random regression with imputed values for dropouts.
    Overall JE; Shobaki G; Fiore J
    Psychopharmacol Bull; 1996; 32(3):377-88. PubMed ID: 8961781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A marginalized pattern-mixture model for longitudinal binary data when nonresponse depends on unobserved responses.
    Wilkins KJ; Fitzmaurice GM
    Biostatistics; 2007 Apr; 8(2):297-305. PubMed ID: 16787997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
    Lesaffre E; Molenberghs G; Dewulf L
    Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of incomplete longitudinal binary data using multiple imputation.
    Li X; Mehrotra DV; Barnard J
    Stat Med; 2006 Jun; 25(12):2107-24. PubMed ID: 16220495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analyzing incomplete longitudinal clinical trial data.
    Molenberghs G; Thijs H; Jansen I; Beunckens C; Kenward MG; Mallinckrodt C; Carroll RJ
    Biostatistics; 2004 Jul; 5(3):445-64. PubMed ID: 15208205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of statistical analysis in open extension studies.
    Yazici Y; Yazici H
    J Rheumatol; 2006 Feb; 33(2):437; author reply 437-8. PubMed ID: 16465682
    [No Abstract]   [Full Text] [Related]  

  • 14. Testing for treatment differences with dropouts present in clinical trials--a composite approach.
    Troendle JF
    Stat Med; 1998 May; 17(9):1062-4. PubMed ID: 9612891
    [No Abstract]   [Full Text] [Related]  

  • 15. [Interpretation of clinical studies].
    Jahrmäker H
    Med Klin (Munich); 1995 Jan; 90(1):45-52. PubMed ID: 7885305
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bayesian framework for intent-to-treat analysis with missing data.
    Kleinman KP; Ibrahim JG; Laird NM
    Biometrics; 1998 Mar; 54(1):265-78. PubMed ID: 9544521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial.
    Yang X; Shoptaw S
    Drug Alcohol Depend; 2005 Mar; 77(3):213-25. PubMed ID: 15734221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From trial and error to trial simulation. Part 1: the importance of model-based drug development for antidepressant drugs.
    Santen G; van Zwet E; Danhof M; Della Pasqua O
    Clin Pharmacol Ther; 2009 Sep; 86(3):248-54. PubMed ID: 19657333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical handling of drop-outs in longitudinal clinical trials.
    Harris RI
    Stat Med; 1993 Dec; 12(23):2248-50. PubMed ID: 8310194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.